OPKO Health's (OPK) CEO Phillip Frost on Q3 2016 Results - Earnings Call Transcript

SA Transcripts
151.23K Followers

Q3: 2016-11-07 Earnings Summary

EPS of -$0.03 misses by $0.00 | Revenue of $298.04M (108.42% Y/Y) misses by $23.99M

OPKO Health, Inc. (NASDAQ:OPK) Q3 2016 Earnings Conference Call November 7, 2016 4:30 PM ET

Executives

Bruce Voss - LHA
Phillip Frost - Chairman and Chief Executive Officer
Steven Rubin - Executive Vice President, Administration
Adam Logal - Senior Vice President and Chief Financial Officer
David Okrongly - President, Diagnostics
Jane Hsiao - Vice-Chairman and Chief Technical Officer
Charles Bishop - CEO, Renal Division

Analysts

Dana Flanders - JPMorgan
Yale Jen - Laidlaw and Company.
Kevin DeGeeter - Ladenburg

Operator

Welcome to the OPKO Health Third Quarter 2016 Financial Results. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we’ll hold a Q&A session. [Operator Instructions] As a reminder, this conference is being recorded today Monday November 7, 2016.

I would like to turn the call over to Mr. Bruce Voss. Sir, please go ahead.

Bruce Voss

Thank you. Good afternoon. This is Bruce Voss with LHA. Thank you all for joining today’s call. Before we begin, I’d like to remind you that any statements made during this call other than statements of historical fact will be considered forward-looking and as such will be subject to risks and uncertainties that could materially affect the company’s expected results, including, without limitation, the various risks described in the company’s annual report on Form 10-K for the year ended December 31, 2015 and its subsequent filings with the SEC.

Before we begin, let me review the format for today’s call. Dr. Phillip Frost, Chairman and Chief Executive Officer of OPKO, will provide opening remarks, Steven Rubin, OPKO’s Executive Vice President, will then provide an update on the company’s various businesses and clinical programs, and Adam Logal, Chief Financial Officer, will provide an overview of the company’s financial performance during the quarter. We will then open the call up to your questions, after which Dr. Frost will close the call with some final

Recommended For You

About OPK Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on OPK